Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03120871 · ClinicalTrials.gov registry record
Microbiome Insulin Sensitivity Study
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 54
- Enrollment target
NCT03120871 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 54 participants.
The verdict
NCT03120871 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 54 participants
- Enrollment target
Study Summary
The Microbiome Insulin Sensitivity Study "MISS" is a pilot study designed to study microbiome composition across puberty and how it relates to insulin sensitivity and secretion in obese girls, who are at increased risk for developing type 2 diabetes in puberty. The investigators will evaluate the gut microbiome composition in fecal samples of 57 obese girls in three groups: prepubertal (Tanner 1), early pubertal (Tanner 2-3), and late pubertal (Tanner 4-5). Insulin sensitivity will also be measured via an intravenous glucose tolerance test (IVGTT) in 18 prepubertal and late pubertal participants.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2017-05-12 |
| Est. Completion | 2018-08-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03120871
The ClinicalTrials.gov registry entry for NCT03120871 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03120871 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03120871 about?
NCT03120871 is a clinical study titled "Microbiome Insulin Sensitivity Study". The Microbiome Insulin Sensitivity Study "MISS" is a pilot study designed to study microbiome composition across puberty and how it relates to insulin sensitivity and secretion in obese girls, who are at increased risk for developing type 2 diabetes in puberty. The investigators will evaluate the gu...
What is the current status of trial NCT03120871?
This trial is currently completed. The enrollment target is 54 participants. The study started on 2017-05-12. Estimated completion is 2018-08-19.
Who is sponsoring clinical trial NCT03120871?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.